SCHEMBL5944409

SCHEMBL5944409

c1ccc(-c2ccc(-c3cccc(-c4cccc(-n5c6ccccc6c6ncccc65)n4)n3)cc2)nc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.41
▸ TP53 P04637 2/20 0.41
▸ SMN1; SMN2 Q16637 2/20 0.41
▸ LMNA P02545 1/20 0.41
▸ ALPL P05186 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ ALPI P09923 1/20 0.41
▸ ALPG P10696 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ CCR1 P32246 1/20 0.41
▸ HTT P42858 1/20 0.41
▸ CCR5 P51681 1/20 0.41
▸ CCR8 P51685 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ IRAK4 Q9NWZ3 2/20 0.37
▸ DHODH Q02127 2/20 0.36
▸ MAPT P10636 3/20 0.36
▸ KMT2A Q03164 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4561428 0.94 TOP1 (0.35) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL4562144 0.93 KDM4E (0.40) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL4562150 0.93 KMT2A (0.40) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL4562438 0.92 RAB9A (0.42) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL4562434 0.91 MAPT (0.36) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL2693505 0.91 KDM4E (0.42) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL4562395 0.90 TOP1 (0.43) LMNAMAPTKMT2ACYP2C9MAPK14
SCHEMBL5944422 0.90 PDE4A (0.37) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL4561407 0.89 KDM4E (0.39) KDM4ETP53SMN1; SMN2LMNAALPL
SCHEMBL15706680 0.88 HTR1A (0.33) KDM4ETP53SMN1; SMN2LMNAALPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722209-B2 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element HODOGAYA CHEMICAL CO., LTD. (JP) 2014-05-13 — — US disclosed
US-8722209-B2 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element HODOGAYA CHEMICAL CO., LTD. (JP) 2014-05-13 — — US disclosed
US-20120298969-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2012-11-29 — — US disclosed
US-20120298969-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2012-11-29 — — US disclosed
EP-2457912-A1 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element Hodogaya Chemical Co., Ltd. (JP) 2012-05-30 — — EP disclosed
EP-2053051-B1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO LTD (JP) 2012-05-02 — — EP disclosed
US-8168308-B2 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element HODOGAYA CHEMICAL CO., LTD. (JP) 2012-05-01 — — US disclosed
US-8168308-B2 Compound having pyridoindole ring structure having substituted pyridyl group attached thereto, and organic electroluminescence element HODOGAYA CHEMICAL CO., LTD. (JP) 2012-05-01 — — US disclosed
US-20100230660-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2010-09-16 — — US disclosed
US-20100230660-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT HODOGAYA CHEMICAL CO., LTD. (JP) 2010-09-16 — — US disclosed
EP-2053051-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT Hodogaya Chemical Co., Ltd. (JP) 2009-04-29 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100230660-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT SCO2, PNPO, WEE1 KDM4E 690/4885TP53 4217/4885SMN1; SMN2 3613/4885
US-20120298969-A1 COMPOUND HAVING PYRIDOINDOLE RING STRUCTURE HAVING SUBSTITUTED PYRIDYL GROUP ATTACHED THERETO, AND ORGANIC ELECTROLUMINESCENCE ELEMENT PNPO, SCO2, OR10J3 KDM4E 1532/4885TP53 4146/4885SMN1; SMN2 4354/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback